VCM
AURA icon

Versant Capital Management’s Aura Biosciences AURA Stock Holding History

Versant Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.26K Sell
1,023
-438
-30% -$3.13K ﹤0.01% 2337
2026
Q1 		$9.77K Buy
1,461
+668
+84% +$3.83K ﹤0.01% 2148
2025
Q4 		$4.32K Buy
+793
New +$4.71K ﹤0.01% 2300
2025
Q3 		– Sell
-659
Closed -$4.13K – 2643
2025
Q2 		$4.13K Sell
659
-635
-49% -$3.71K ﹤0.01% 2220
2025
Q1 		$7.58K Buy
+1,294
New +$9.79K ﹤0.01% 1862

Other funds holding AURA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Versant Capital Management's AURA Position: Q2 2026 in Review

Versant Capital Management reduced its Aura Biosciences (AURA) stake by 30% in Q2 2026, selling an estimated $3.13K and leaving 1,023 shares worth $7.26K. The position accounts for ﹤0.01% of the portfolio, ranked #2337.

Versant Capital Management first reported a position in AURA in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.77K in Q1 2026. 8 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Versant Capital Management held 1,023 shares of Aura Biosciences worth $7.26K as of Q2 2026.
  • Versant Capital Management sold 438 Aura Biosciences shares in Q2 2026, an estimated $3.13K.
  • Aura Biosciences made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2337 holding.
  • Versant Capital Management first reported a position in Aura Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Versant Capital Management's Aura Biosciences position peaked at $9.77K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.